Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Dec;18(6):930–932. doi: 10.1128/aac.18.6.930

Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells.

A K Field, E M Scattergood, C J Hopke, A A Tytell, M R Hilleman
PMCID: PMC352991  PMID: 6165322

Abstract

Growth and interferon production by human lymphoblastoid cells (Namalva) have been achieved by using medium with a complete substitution of human albumin for fetal bovine serum. Medium containing 0.3% human albumin supported exponential cell growth (minimum doubling time, 20 h) in Bilthoven 10-liter fermentors. Interferon induction with Sendai virus resulted in interferon yields of 0.5 x 10(4) to 1.0 x 10(4) interferon units per 10(6) Namalva cells per ml in RPMI 1640 medium containing 0.15 to 0.3% human albumin. Both cell growth and interferon production in medium containing human albumin were comparable to growth and interferon production in the same medium containing 10 and 5% fetal bovine serum, respectively.

Full text

PDF
930

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cantell K., Hirvonen S. Preparation of human leukocyte interferon for clinical use. Tex Rep Biol Med. 1977;35:138–144. [PubMed] [Google Scholar]
  2. Dunnick J. K., Galasso G. J. Clinical trials with exogenous interferon: summary of a meeting. J Infect Dis. 1979 Jan;139(1):109–123. doi: 10.1093/infdis/139.1.109. [DOI] [PubMed] [Google Scholar]
  3. Havell E. A., Yip Y. K., Vilcek J. Characteristics of human lymphoblastoid (Namalva) interferon. J Gen Virol. 1978 Jan;38(1):51–59. doi: 10.1099/0022-1317-38-1-51. [DOI] [PubMed] [Google Scholar]
  4. Klein F., Ricketts R. T., Jones W. I., DeArmon I. A., Temple M. J., Zoon K. C., Bridgen P. J. Large-scale production and concentration of human lymphoid interferon. Antimicrob Agents Chemother. 1979 Mar;15(3):420–427. doi: 10.1128/aac.15.3.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Strander H. Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man. Tex Rep Biol Med. 1977;35:429–435. [PubMed] [Google Scholar]
  6. Strander H., Mogensen K. E., Cantell K. Production of human lymphoblastoid interferon. J Clin Microbiol. 1975 Jan;1(1):116–117. doi: 10.1128/jcm.1.1.116-117.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Zoon K. C., Bridgen P. J., Smith M. E. Production of human lymphoblastoid interferon by Namalwa cells cultured in serum-free media. J Gen Virol. 1979 Jul;44(1):227–229. doi: 10.1099/0022-1317-44-1-227. [DOI] [PubMed] [Google Scholar]
  8. Zoon K. C., Buckler C. E., Bridgen P. J., Gurari-Rotman D. Production of human lymphoblastoid interferon by Namalva cells. J Clin Microbiol. 1978 Jan;7(1):44–51. doi: 10.1128/jcm.7.1.44-51.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. van Hemert P. Vaccine production as a unit process. Prog Ind Microbiol. 1974;13:151–271. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES